All three trials in the Company’s registrational ECLIPSE program for chronic hepatitis delta (CHD) have now been initiated.

ECLIPSE is a registrational program to evaluate the safety and efficacy of tobevibart in combination with elebsiran in patients with chronic hepatitis delta (CHD).

Today also marks 20 years until the "next big total solar eclipse" in the U.S, "one of the most impressive of the century," ...

SAN FRANCISCO, August 06, 2025--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the enrollment of the first participant in ECLIPSE 3. All three trials in the Company’s registrational ...

A New York-based start-up company wants to use batteries to reduce stress on the energy grid and put money back in the pockets of state residents.

NASA official says agency innovations in rocket propulsion, AI, and testing infrastructure could could support Golden Dome missile defense initiative ...

The Centers for Medicare & Medicaid Services will use AI to help make prior authorization decisions.

There are more than 198,000 students in the School District of Philadelphia, and nearly a quarter of them rely on SEPTA to get to class.

A partial solar eclipse is taking place just hours before the equinox flips Earth's seasons in September 2025. Here's where a few lucky humans will be able to see it.